Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get all the relevant market information you need — get it fast, on time, and accurately. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or
Bausch Lomb Corporation (BLCO.TO)
Bausch Lomb Corporation (BLCO.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 8,644,370
  • Shares Outstanding, K 350,258
  • Annual Sales, $ 3,768 M
  • Annual Income, $ 6,000 K
  • 60-Month Beta N/A
  • Price/Sales 1.70
  • Price/Cash Flow 22.59
  • Price/Book 0.93
Trade BLCO.TO with:
  • Price/Earnings ttm N/A
  • Earnings Per Share ttm -0.30
  • Most Recent Earnings -0.26 on 05/03/23
  • Next Earnings Date N/A
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

    TSX Medical Instruments & Suppls

Price Performance

See More
Period Period Low Period High Performance
1-Month
23.85 +3.48%
on 05/31/23
26.70 -7.57%
on 05/17/23
-0.02 (-0.08%)
since 05/09/23
3-Month
21.09 +17.02%
on 03/15/23
26.70 -7.57%
on 05/17/23
+2.20 (+9.79%)
since 03/09/23
52-Week
15.95 +54.73%
on 07/28/22
26.70 -7.57%
on 05/17/23
+6.19 (+33.48%)
since 06/09/22

Most Recent Stories

More News
Stocks in play: Bausch + Lomb Corporation

Announced a reshaping of its executive leadership team, including the elevation of all business unit ...

BLCO.TO : 24.68 (-0.76%)
Bausch + Lomb Announces First-Quarter 2023 Results and Provides 2023 Guidance

Bausch + Lomb Corporation, (NYSE/TSX: BLCO) (“Bausch + Lomb” or the “Company”, “we” or “our”), a leading global eye health company dedicated to helping people see better to live better,...

BLCO : 18.49 (-0.11%)
BLCO.TO : 24.68 (-0.76%)
Bausch + Lomb Releases Annual Environmental, Social and Governance Report

Bausch + Lomb Corporation, (NYSE/TSX: BLCO) (“Bausch + Lomb” or the “Company”, “we” or “our”), a leading global eye health company dedicated to helping people see better to live better,...

BLCO : 18.49 (-0.11%)
BLCO.TO : 24.68 (-0.76%)
Bausch + Lomb Announces the Presentation of New Scientific Data on Products and Pipeline Programs at the American Society of Cataract and Refractive Surgery Annual Meeting

Bausch + Lomb Corporation (NYSE/TSX: BLCO) (“Bausch + Lomb”), a leading global eye health company dedicated to helping people see better to live better, today announced the presentation of 21 podium...

BLCO : 18.49 (-0.11%)
BLCO.TO : 24.68 (-0.76%)
Bausch + Lomb Announces 2023 Annual Meeting of Shareholder Results

Bausch + Lomb Corporation (NYSE/TSX: BLCO) (“Bausch + Lomb” or the “Company”), a leading global eye health company dedicated to helping people see better to live better, today announced the election...

BLCO : 18.49 (-0.11%)
BLCO.TO : 24.68 (-0.76%)
Bausch + Lomb Announces U.S. Launch of StableVisc™ Cohesive Ophthalmic Viscosurgical Device and TotalVisc™ Viscoelastic System

Bausch + Lomb Corporation (NYSE/TSX: BLCO) (“Bausch + Lomb”), a leading global eye health company dedicated to helping people see better to live better, today announced the U.S. launch of StableVisc™...

BLCO : 18.49 (-0.11%)
BLCO.TO : 24.68 (-0.76%)
Bausch + Lomb Announces the Presentation of New Data on Products and Pipeline Programs at the Association for Research in Vision and Ophthalmology Meeting

Bausch + Lomb Corporation (NYSE/TSX: BLCO) (“Bausch + Lomb”), a leading global eye health company dedicated to helping people see better to live better, today announced the presentation of eight scientific...

BLCO : 18.49 (-0.11%)
BLCO.TO : 24.68 (-0.76%)
Bausch + Lomb Reports More Than 65 Million Units of Contact Lens, Eye Care and Lens Care Materials Recycled Through ONE by ONE and Biotrue® Eye Care Recycling Programs

Bausch + Lomb Corporation (NYSE/TSX: BLCO) (“Bausch + Lomb”), a leading global eye health company dedicated to helping people see better to live better, today announced its exclusive ONE by ONE and...

BLCO : 18.49 (-0.11%)
BLCO.TO : 24.68 (-0.76%)
Bausch + Lomb Will Release First-Quarter 2023 Financial Results on May 3

Bausch + Lomb Corporation (NYSE/TSX: BLCO) (“Bausch + Lomb”), a leading global eye health company dedicated to helping people see better to live better, will release its first-quarter 2023 financial...

BLCO : 18.49 (-0.11%)
BLCO.TO : 24.68 (-0.76%)
Stocks in play: Bausch + Lomb

And Heidelberg Engineering, today announced the introduction of the SeeLuma™ Fully Digital Surgical ...

BLCO.TO : 24.68 (-0.76%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Buy with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Key Turning Points

3rd Resistance Point 24.83
2nd Resistance Point 24.80
1st Resistance Point 24.74
Last Price 24.68
1st Support Level 24.65
2nd Support Level 24.62
3rd Support Level 24.56

See More

52-Week High 26.70
Last Price 24.68
Fibonacci 61.8% 22.59
Fibonacci 50% 21.33
Fibonacci 38.2% 20.06
52-Week Low 15.95

See More

Business Summary

Bausch & Lomb is one of the largest vision care companies in the U.S. The firm was previously a subsidiary under parent company Bausch Health and it was spun off to become a public company in 2022. It operates in three segments: vision care, surgical, and ophthalmic pharmaceuticals. Vision care is composed...

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar